CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo - Kim, J Y; Min, J Y; Baek, J M (Bone, 2015)
et al.